Ticker: STOK

Company: Stoke Therapeutics, Inc.

Person: Jonathan Allan, officer

Transaction date: Dec. 3, 2025

Reporting date: Dec. 5, 2025

Average share price: 80.54750134104653

Sold 3803.0 shares for 306322.15